Lonza Group AG
LZAGF · SWISS
$761.21+$16.21 (+2.18%)TodayMarket closed ·
Prev close $745.00
EPS: actual vs estimate
Beat the estimate in 3 of the last 8 quarters, by 16.1% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $9.07 | $8.61 | −5.1% |
| Q4 FY25 | $9.66 | $7.52 | −22.2% |
| Q2 FY25 | $7.00 | $7.51 | +7.2% |
| Q4 FY24 | $7.48 | $7.99 | +6.8% |
| Q2 FY24 | $5.22 | $7.02 | +34.4% |
| Q4 FY23 | $6.80 | $6.27 | −7.7% |
| Q2 FY23 | $7.13 | $6.12 | −14.2% |
| Q4 FY22 | $7.46 | $7.43 | −0.4% |
Earnings calls
- Analyst/Investor Day - Lonza Group AG
- Morgan Stanley 24th Annual Global Healthcare Conference
- LONN.SW - Earnings call Q2 2026
- LONN.SW - Earnings call Q1 2026
- Special Call - Lonza Group AG
- 2025 Earnings Call
- 44th Annual J.P. Morgan Healthcare Conference
- LONN.SW - Earnings call Q3 2025
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.